Pathophysiology and prevention of sudden cardiac death.
暂无分享,去创建一个
[1] M. Sheppard,et al. Sudden cardiac death with stress and restraint: The association with sudden adult death syndrome, cardiomyopathy and coronary artery disease , 2016, Medicine, science, and the law.
[2] M. Sheppard. Sudden cardiac death , 2015, European heart journal.
[3] A. Kowalczyk,et al. Desmosomes in acquired disease , 2015, Cell and Tissue Research.
[4] J. DiNicolantonio,et al. β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature , 2015, Open Heart.
[5] G. Thiene. Sudden cardiac death and cardiovascular pathology: from anatomic theater to double helix. , 2014, The American journal of cardiology.
[6] J. Francis,et al. Update on Ventricular Tachyarrhythmias and Related Sudden Cardiac Death , 2014, Indian pacing and electrophysiology journal.
[7] Rajiv Gulati,et al. Sudden cardiac death from the perspective of coronary artery disease. , 2014, Mayo Clinic proceedings.
[8] K. Hebert,et al. EKG Pattern of Brugada Syndrome and Sudden Infant Death Syndrome—Is It Time to Review the Diagnostic Criteria? Case Report and Review of Literature , 2014, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[9] J. van der Velden,et al. The physiological role of cardiac cytoskeleton and its alterations in heart failure. , 2014, Biochimica et biophysica acta.
[10] J. Resar,et al. Diagnosis and Management of Valvular Aortic Stenosis , 2014, Clinical Medicine Insights. Cardiology.
[11] H. Huikuri,et al. Electrocardiographic predictors of sudden cardiac death from a large Finnish general population cohort. , 2013, Journal of electrocardiology.
[12] W. Saliba,et al. Role of CMR imaging in risk stratification for sudden cardiac death. , 2013, JACC. Cardiovascular imaging.
[13] Claudia Giambartolomei,et al. Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing , 2013, Journal of Medical Genetics.
[14] D. Corrado,et al. Arrhythmogenic right ventricular cardiomyopathy. , 2012, Circulation. Arrhythmia and electrophysiology.
[15] B. Murray. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C): A Review of Molecular and Clinical Literature , 2012, Journal of Genetic Counseling.
[16] Jin-fang Xu,et al. Effects of Combined Aspirin and Clopidogrel Therapy on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis , 2012, PloS one.
[17] Peng-Sheng Chen,et al. Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy. , 2011, Human molecular genetics.
[18] Kevin L. Thomas,et al. Systematic review of the incidence of sudden cardiac death in the United States. , 2011, Journal of the American College of Cardiology.
[19] G. Radice,et al. Cardiac Tissue-Restricted Deletion of Plakoglobin Results in Progressive Cardiomyopathy and Activation of β-Catenin Signaling , 2011, Molecular and Cellular Biology.
[20] C. Ram,et al. Beta-blockers in hypertension. , 2010, The American journal of cardiology.
[21] N. Dhalla,et al. Role of catecholamine oxidation in sudden cardiac death , 2010, Fundamental & clinical pharmacology.
[22] J. Cruickshank. β blockers in hypertension , 2010, The Lancet.
[23] Erica E Valenti,et al. Sudden cardiac death athletes: a systematic review , 2010, Sports medicine, arthroscopy, rehabilitation, therapy & technology : SMARTT.
[24] M. Hayward,et al. Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.
[25] N. Dhalla,et al. Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease. , 2009, Canadian journal of physiology and pharmacology.
[26] S. Berger,et al. Sudden Cardiac Death in Children and Adolescents: Introduction and Overview , 2009, Pacing and clinical electrophysiology : PACE.
[27] Kirk U. Knowlton,et al. Viral Myocarditis: From the Perspective of the Virus , 2009, Circulation.
[28] R. Gow. Preventing sudden cardiac death in the young: Is electrocardiogram screening the most effective means? , 2009, Paediatrics & child health.
[29] A. Go,et al. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice. , 2008, Archives of internal medicine.
[30] C. Angermann,et al. Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community‐based sample of patients with chronic heart failure A prospective cohort study , 2008, European journal of heart failure.
[31] J. Butany,et al. Dilated cardiomyopathy: a review , 2008, Journal of Clinical Pathology.
[32] Sandeep N. Gupta,et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.
[33] A. Wilde,et al. Do patients with long QT syndrome remain at risk for sudden cardiac death after 40 years of age? , 2008, Nature Clinical Practice Cardiovascular Medicine.
[34] Jae‐Hyeong Park,et al. Acquired long QT syndrome and sudden cardiac death due to secondary hemochromatosis with multitransfusions for severe aplastic anemia , 2008, Annals of Hematology.
[35] Heidi L Rehm,et al. Shared genetic causes of cardiac hypertrophy in children and adults. , 2008, The New England journal of medicine.
[36] H. Calkins,et al. Mechanisms of Disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy , 2008, Nature Clinical Practice Cardiovascular Medicine.
[37] P. Klír,et al. [Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) as a cause of sudden death]. , 2008, Soudni lekarstvi.
[38] J. Saenen,et al. Molecular aspects of the congenital and acquired Long QT Syndrome: clinical implications. , 2008, Journal of molecular and cellular cardiology.
[39] R. Higgins,et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. , 2008, The New England journal of medicine.
[40] Dan M. Roden,et al. Clinical practice. Long-QT syndrome. , 2008, The New England journal of medicine.
[41] P. Hoff,et al. [Risk factors for sudden cardiac death related to the long QT syndrome]. , 2006, Tidsskrift for Den Norske Laegeforening.
[42] Michael D. Schneider,et al. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. , 2006, The Journal of clinical investigation.
[43] A. Steptoe,et al. Platelets, coronary heart disease, and stress , 2006, Brain, Behavior, and Immunity.
[44] M. Hauser. Congenital anomalies of the coronary arteries , 2005, Heart.
[45] G. Danieli,et al. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. , 2005, European heart journal.
[46] B. Maron,et al. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. , 2005, The American journal of cardiology.
[47] E. Corwin,et al. ARVD: A Silent Killer , 2005, The Nurse practitioner.
[48] G. Vincent,et al. The Long QT and Brugada syndromes: causes of unexpected syncope and sudden cardiac death in children and young adults. , 2005, Seminars in pediatric neurology.
[49] R. Kandolf,et al. High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With “Idiopathic” Left Ventricular Dysfunction , 2005, Circulation.
[50] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[51] E. Bramucci,et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. , 2004, JAMA.
[52] Dudley J Pennell,et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.
[53] D. Malicier,et al. Circumstances of Death and Gross and Microscopic Observations in a Series of 200 Cases of Sudden Death Associated With Arrhythmogenic Right Ventricular Cardiomyopathy and/or Dysplasia , 2003, Circulation.
[54] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[55] M. Kirk,et al. Primary Prevention of Sudden Cardiac Death: Trials in Patients with Coronary Artery Disease , 2003, Journal of Interventional Cardiac Electrophysiology.
[56] B. Z. Etayo,et al. Estenosis aórtica asintomática y muerte súbita , 2003 .
[57] L. Hillis,et al. Diagnostic Cardiac Catheterization , 2003, Circulation.
[58] R. Kim,et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study , 2003, The Lancet.
[59] B. Maron,et al. Hypertrophic Cardiomyopathy , 2002, Lancet.
[60] F. Ruschitzka,et al. Mental Stress Induces Prolonged Endothelial Dysfunction via Endothelin-A Receptors , 2002, Circulation.
[61] P. Serruys,et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. , 2002, The New England journal of medicine.
[62] A. Banes,et al. Different alpha-adrenoceptors mediate migration of vascular smooth muscle cells and adventitial fibroblasts in vitro. , 2002, American journal of physiology. Heart and circulatory physiology.
[63] B. Maron. Risk Stratification and Prevention of Sudden Death in Hypertrophic Cardiomyopathy , 2002, Cardiology in review.
[64] B. Maron. Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.
[65] John Ross,et al. Dilated cardiomyopathy: concepts derived from gene deficient and transgenic animal models. , 2002, Circulation journal : official journal of the Japanese Circulation Society.
[66] G. Rollins. Aspirin therapy now recommended for people at risk for heart disease. , 2002, Report on medical guidelines & outcomes research.
[67] A. Marian,et al. Molecular genetics and pathogenesis of hypertrophic cardiomyopathy. , 2001, Minerva medica.
[68] M. Novak,et al. Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes) , 2001, Journal of applied toxicology : JAT.
[69] T. Meinertz,et al. Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.
[70] J P Ornato,et al. Cardiology patient page: warning signs of a heart attack. , 2001, Circulation.
[71] G. Rollins. Low daily aspirin doses reduce risk of blood clots as effectively as higher doses. , 2001, Report on medical guidelines & outcomes research.
[72] F. Cecchin,et al. Major coronary artery anomalies in a pediatric population: incidence and clinical importance. , 2001, Journal of the American College of Cardiology.
[73] P. Caroni,et al. Decreased expression of the cardiac LIM domain protein MLP in chronic human heart failure. , 2000, Circulation.
[74] N. Dhalla,et al. Role of oxidative stress in cardiovascular diseases , 2000, Journal of hypertension.
[75] Nick Freemantle,et al. β Blockade after myocardial infarction: systematic review and meta regression analysis , 1999 .
[76] J. Nagle,et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy , 1998, Nature Genetics.
[77] B. Maron. Risk profiles and cardiovascular preparticipation screening of competitive athletes. , 1997, Cardiology clinics.
[78] A. Coumbe,et al. 4. Arrhythmogenic Right Ventricular Dysplasia (ARVD): An Overlooked and Underdiagnosed Condition? , 1997, Medicine, science, and the law.
[79] M. Böhm,et al. The Cardiac β-Adrenoceptor–Mediated Signaling Pathway and Its Alterations in Hypertensive Heart Disease , 1997 .
[80] R Kemler,et al. Embryonic heart and skin defects in mice lacking plakoglobin. , 1996, Developmental biology.
[81] A. Angelini,et al. Spin-echo nuclear magnetic resonance for tissue characterisation in arrhythmogenic right ventricular cardiomyopathy. , 1996, Heart.
[82] A. Angelini,et al. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? , 1996, Circulation.
[83] A. Angelini,et al. Endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy. , 1996, American heart journal.
[84] B Maisch,et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.
[85] P C Deedwania,et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.
[86] B. Eriksson,et al. Dilated cardiomyopathy and the dystrophin gene: an illustrated review. , 1994, British heart journal.
[87] H. Doval,et al. Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.
[88] G. Hutchins,et al. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. , 1994, Journal of the American College of Cardiology.
[89] T. Martino,et al. Viral infection and the pathogenesis of dilated cardiomyopathy. , 1994, Circulation research.
[90] M. Steinfath,et al. Reduced α1‐ and β2‐adrenoceptor‐mediated positive inotropic effects in human end‐stage heart failure , 1992 .
[91] W. Shimizu,et al. [Arrhythmogenic right ventricular dysplasia (ARVD)]. , 1991, Nihon rinsho. Japanese journal of clinical medicine.
[92] K. Stajduhar,et al. Anomalous origin and course of coronary arteries in adults: identification and improved imaging utilizing transesophageal echocardiography. , 1991, American heart journal.
[93] B. Maron,et al. Prospective identification by two-dimensional echocardiography of anomalous origin of the left main coronary artery from the right sinus of Valsalva. , 1991, The American journal of cardiology.
[94] R. Hobbs,et al. Coronary artery anomalies in 126,595 patients undergoing coronary arteriography. , 1990, Catheterization and cardiovascular diagnosis.
[95] V. Friedewald,et al. Sudden cardiac death associated with exercise: the risk-benefit issue. , 1990, The American journal of cardiology.
[96] B. Maron,et al. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. , 1990, Journal of the American College of Cardiology.
[97] H. Kulbertus. Ventricular arrhythmias, syncope and sudden death in aortic stenosis. , 1988, European heart journal.
[98] B. Maron,et al. Diastolic abnormalities in patients with hypertrophic cardiomyopathy: relation to magnitude of left ventricular hypertrophy. , 1985, Circulation.
[99] V L Gott,et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. , 1980, The New England journal of medicine.
[100] J. Haft,et al. Intravascular Platelet Aggregation in the Heart Induced by Norepinephrine: Microscopic Studies , 1972, Circulation.
[101] J. Ogden,et al. Congenital anomalies of the coronary arteries. , 1970, The American journal of cardiology.
[102] R. Bonow. Hypertrophic cardiomyopathy: past, present… and future. , 2015, Trends in cardiovascular medicine.
[103] M. Ackerman. Unmasking concealed long QT syndrome. , 2008, Heart Rhythm.
[104] H. Calkins,et al. Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study. , 2008, American heart journal.
[105] A. Zeiher,et al. Endothelial Function Cardiac Events , 2005 .
[106] A. Iskandrian,et al. Sudden death in severe aortic stenosis following cardiac catheterization. , 1978, Catheterization and cardiovascular diagnosis.
[107] J. Murray,et al. Effect of aortocoronary saphenous vein bypass grafting on death and sudden death. Comparison of nonrandomized medically and surgically treated cohorts with comparable coronary disease and left ventricular function. , 1977, The American journal of cardiology.